A universal light-controlled highly sensitive one-pot CRISPR/Cas12a diagnostic based on structure-engineered crRNA
Jieyu Cui, Lulu Zhang, Jing Zhou, Ting Shi, Shangyi Wu, Tenghui Dai, Lijun Hao, Junjie Pan, Xiaodan Lai, Wentao Lu, Xingxu Huang, Zhanjun Li, Liangxue Lai, Xinjie Wang
Journal:TRENDS IN BIOTECHNOLOGY
IF:16.6
DOI:10.1016/j.tibtech.2026.03.018
PMID:41966922
Published:2026-04-10
research field:核酸检测生物医学工程CRISPR技术分子诊断病毒学
Abstract
Clustered regularly interspaced short palindromic repeats (CRISPR)-based nucleic acid detection has transformed molecular diagnostics through its speed and accuracy; however, one-pot formats are often limited by sensitivity and field suitability. Herein, we developed a u niversal l ight-con t rolled high-sensitivity one-pot CRISP R /Cas12 a tes t ing (ULTRAt) platform based on structure-engineered CRISPR RNA (crRNA) scaffolds. By incorporating photocaged 6-nitropiperonyloxymethyl groups into the crRNA stem-loop, Cas12a activity is transiently suppressed during isothermal amplification via structural modulation, enabling efficient target enrichment. Subsequent UV irradiation removes the protecting groups, restoring the native conformation and activating robust trans -cleavage. ULTRAt achieves a limit of detection of two copies of monkeypox virus per reaction with a 15-min time-to-result, representing a 100-fold sensitivity improvement over conventional assays. The platform further supports single-nucleotide polymorphism discrimination and human papillomavirus 16/18 genotyping. Analysis of 91 clinical samples demonstrates strong concordance between ULTRAt and reference qPCR and sequencing assays. Collectively, ULTRAt enables rapid, ultra-sensitive, and versatile one-pot detection, supporting near-patient diagnostics and genotyping.
本文使用的Yeasen产品


